Advanced search×

Alzheimer's disease: paired helical filaments and cytomembranes.

Neuropathol Appl Neurobiol 13(2):91-110 (1987) PMID 3614544

Observations were made with the electron microscope on biopsies from the frontal cerebral cortex of four patients showing the clinical symptoms of advanced Alzheimer's disease (AD). Sections from all four biopsies showed neuronal dendrites, and to a lesser extent, perikarya, packed with paired helical filaments (PHFs) and a correlated complete loss of the normal content of microtubules. It was usually impossible to visualize the beginning and end of the PHF since it passed out of the plane of section. However, not infrequently, PHFs could be seen apparently arising at or from the surfaces of cytomembranes. Such membranes (in perikarya or dendrite) often formed irregular stacks or lamellated bodies. These membranes were invariably agranular (i.e. not studded with ribosomes) and so might be considered as pathological forms of smooth endoplasmic reticulum (SER). A correlation is established between the known biochemical nature of PHFs and their postulated membrane origin.

DOI: 10.1111/j.1365-2990.1987.tb00174.x
Version: za2963e q8za3 q8zbe q8zcd q8zd2 q8ze5 q8zfd q8zga

Similar articles you may find interesting…

  1. NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role...

    J Neurosci 27(21):5766-76 (2007) PMID 17522320

    We show that injection of NP031112, a more potent thiadiazolidinone derivative, into the rat hippocampus dramatically reduces kainic acid-induced inflammation, as measured by edema formation using T2-weighted magnetic resonance imaging and glial activation and has a neuroprotective effect in the dam...
  2. Helicobacter pylori Chronic Gastritis in Children: To Eradicate or Not to Eradicate?

    J Pediatr 159(1):7 (2011) PMID 21392790

    To evaluate the efficacy of triple eradication therapy versus symptomatic therapy in children with Helicobacter pylori-associated chronic active gastritis (H pylori-ACAG).
  3. XL184 (cabozantinib) for medullary thyroid carcinoma.

    Expert Opin Investig Drugs (2011) PMID 21314233

    We review preliminary data on the safety and efficacy of XL184 in metastatic MTC based on an extensive search of the literature, which included published articles, abstracts and website information. In particular, the review focuses on the rationale for using XL184 in advanced MTC. The compound has...